Screener
Crinetics Pharmaceuticals CRNX PP&E (Net)
PP&E (Net) at other companies
Other financials
Where this comes from
Reported directly by Crinetics Pharmaceuticals in its filing.
Tagged under the XBRL concept us-gaap:PropertyPlantAndEquipmentNet.
The source filing: Crinetics Pharmaceuticals’s 10-Q, filed May 7, 2026.
- Filed
- May 7, 2026, 4:21 PM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001658247-26-000040
| Line item | March 31,2026 | December 31,2025 |
|---|---|---|
| Inventory | 3,064 | 2,022 |
| Prepaid expenses and other current assets | 22,361 | 17,839 |
| Total current assets | 1,322,414 | 1,048,342 |
| Property and equipment, net | 13,497 | 14,296 |
| Operating lease right-of-use assets | 39,790 | 40,492 |
| Restricted cash, net of current portion | 800 | 800 |
| Prepaid expenses and other assets, net of current portion | 24,822 | 22,327 |
| TOTAL ASSETS | $1,401,323 | $1,126,257 |
Item 1. Condensed Consolidated Financial Statements (Unaudited)
FAQ
- What is Crinetics Pharmaceuticals's PP&E (net)?
- Crinetics Pharmaceuticals (CRNX) reported PP&E (net) of $13.5M in Q1 2026.
- How has Crinetics Pharmaceuticals's PP&E (net) changed year-over-year?
- Crinetics Pharmaceuticals's PP&E (net) increased by 6.9% year-over-year, from $12.63M to $13.5M.
- What is the long-term trend for Crinetics Pharmaceuticals's PP&E (net)?
- Over 5 years (2020 to 2025), Crinetics Pharmaceuticals's PP&E (net) has grown at a 35.1% compound annual growth rate (CAGR), from $3.18M to $14.3M.
- What does PP&E (net) mean?
- Total property, plant, and equipment minus accumulated depreciation — the net book value of all tangible long-lived assets.
Ask your AI about Crinetics Pharmaceuticals's pp&e (net).
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude